Matt StangeCEO and co-founder of Delic Corp, will discuss the company’s strategic outlook for the remainder of the year and the latest developments at the nation’s largest ketamine supplier, Ketamine Wellness Centers (KWC)
VANCOUVER, BC, June 23, 2022 /CNW/ – Delic Holdings Corp. (“Delic” or the “Company”) (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, has confirmed details regarding the CEO of Delic Corp by Matt Stang virtual attendance at HC Wainwright’s first annual Mental Health Conference on June 27, 2022.
HC Wainwright’s Mental Health Lecture: Neuropsychiatry, Psychedelics and Beyond
June 27, 2022
Held at the Lotte New York Palace Hotel, the inaugural event will feature a full day of company presentations, networking opportunities and one-on-one meetings with investors focused on neuropsychiatry, psychedelics and more. During this year’s conference, Stang will deliver a presentation that will highlight the company’s strategic outlook for the remainder of the year and how the company is well positioned to weather the current mental health crisis. . Stang will also discuss Ketamine Wellness Centers’ long-term growth strategy as the nation’s largest ketamine provider and the company’s latest patient programs, such as the first Veterans Administration (VA) partnership ) with KWC Arizona Clinics and the addition of SPRAVATO® and NAD+. His presentation will be available on June 27 from 7 a.m. ET. For more information on HC Wainwright’s first-ever mental health conference, please visit https://hcwevents.com/psychedelics/.
About Delic Corp.
Delic is a leader in new medicines and treatments for a modern world, improving access to health benefits across the country and reframing the conversation about psychedelics. The company owns and operates a collection of related businesses, including the nation’s largest chain of psychedelic wellness clinics, Ketamine Wellness Centers; the only entity authorized by Health Canada to focus exclusively on the research and development of psilocybin vaporization technology, Delic Laboratories; the first psychedelic wellness event, Meet Delic; and trusted media and e-commerce platforms Reality Sandwich and Delic Radio. Delic is backed by a team of industry and cannabis veterans and a diverse network, whose mission is to provide education, research, high-quality products, and effective treatment options to the masses.
Forward-looking information and statements
This press release contains certain “forward-looking information” within the meaning of applicable Canadian securities laws and may also contain statements that may constitute “forward-looking statements” within the meaning of the safe harbor provisions of the United States Private Securities Litigation Reform. Act of 1995. Such forward-looking information and forward-looking statements are not indicative of historical facts or information or of the current state, but represent only the company’s beliefs regarding future events, plans or objectives, many of which, of by their nature, are inherently uncertain and beyond Delic’s control. Generally, such forward-looking information or forward-looking statements can be identified by the use of forward-looking terminology such as “anticipates”, “expects” or “does not expect”, “is expected”, ” budget”, “expected”, “estimates”, “plans”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of these words and expressions or may contain statements that certain actions, events or results “may”, “could”, “will”, “could” or “will be undertaken”, “will continue”, “will occur” or “will be achieved”. Forward-looking information and forward-looking statements contained herein may include, but are not limited to: information regarding when or on what terms the transaction will be completed; the potential benefits of the Transaction; expected continued growth in the health and wellness sector (and, in particular, related to psychedelics); Delic’s ability to successfully meet business objectives and expectations for other economic, business and/or competitive factors.
By identifying such information and statements in this manner, Delic cautions the reader that such information and statements are subject to known and unknown risks, uncertainties, and other factors that may cause the results, level of activity, performance or actual achievements. of Delic as being materially different from those expressed or implied by such information and statements. These risks and other factors may include, but are not limited to: the risks and uncertainties that the transaction may not close as expected or at all or according to the terms and conditions set forth in the merger agreement; incorrect assessment of the value and potential benefits of the Transaction; the direct and indirect material adverse effects of the COVID-19 pandemic; the inability to obtain future financing on suitable terms; failure to obtain required regulatory and other approvals; the risks inherent in the psychedelic treatment industry; changes in applicable laws and regulations; and failure to comply with applicable laws and regulations.
In addition, in connection with the forward-looking information and forward-looking statements contained in this press release, Delic has made certain assumptions. These assumptions include, but are not limited to: assumptions regarding the time required to negotiate a definitive agreement and settle matters relating to the Transaction; the ability to complete the Transaction; the ability of the parties to obtain, on a timely basis, required regulatory, corporate and other third-party approvals and the satisfaction of other conditions to the completion of the transaction on the proposed terms; the potential impact of the announcement or completion of the Transaction on relationships, including with regulators, employees, suppliers, customers and competitors; changes in general economic, business and political conditions, including changes in financial markets; changes in applicable laws; compliance with extensive government regulations; and diversion of management time on the Transaction.
Should one or more of these risks, uncertainties or other factors materialize, or should assumptions underlying any forward-looking information or statements prove incorrect, actual results may differ materially from those described herein, as anticipated, planned , anticipated, believed, estimated or expected.
Although Delic believes that the assumptions and factors used in the preparation and expectations contained in the forward-looking information and statements are reasonable, undue reliance should not be placed on such information and statements, and no assurances or warranties can be made as such forward-looking information and statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such information and statements. The forward-looking information and forward-looking statements contained in this press release are made as of the date of this press release, and Delic does not undertake to update any forward-looking information and/or forward-looking statements. which are contained or referenced herein, except in compliance with applicable securities laws. All subsequent written and oral forward-looking information and statements attributable to Delic or persons acting on its behalf are expressly qualified in their entirety by this notice.
View original content to download multimedia: https://www.prnewswire.com/news-releases/delic-corp-to-present-vision-for-long-term-growth-and-industry-leading-clinic-developments -at -first-annual-hc-wainwright-mental-health-conference-301574008.html
SOURCE Delic Holdings Inc.
View original content to download multimedia: http://www.newswire.ca/en/releases/archive/June2022/23/c0456.html